Fig. 5From: Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countriesPaired tissue and cervical smear analysis. Ninety-two samples of paired tissue (T) and cervical smear/LBC preparations (CS) from Vietnam were tested. Histograms indicate the Cumulative Methylation-5 (CM-5) levels obtained by QM-MSP in patients diagnosed with (A) Squamous cell carcinoma (SCC), B high-grade squamous intraepithelial lesion (HSIL), C low-grade squamous intraepithelial lesion (LSIL), or D benign lesion. Data were compiled from samples shown in Fig. 3C and Additional file 1: Fig. S5BBack to article page